10-10-2006 Boston Scientific Corp, Natick, Mass, has received FDA approval for its new Harmony™ HiResolution® Bionic Ear System (Harmony System). Developed by the company's Neuromodulation Group, the Harmony System delivers 120 spectral bands, helping to significantly increase hearing potential and quality of life for the severe-to-profoundly deaf. "The Harmony System represents the next generation of cochlear implant technology," says Jeff Greiner, president of Boston Scientific's Neuromodulation Group. "We have brought together unprecedented advancements in science, design and functionality for the user—furthering our commitment to restoring hearing and improving quality of life for those living with hearing loss due to permanent inner ear or auditory nerve damage."